5

Biosimilars: The US Regulatory Framework

Year:
2017
Language:
english
File:
PDF, 362 KB
english, 2017
12

FDA pharmaceutical quality oversight

Year:
2015
Language:
english
File:
PDF, 463 KB
english, 2015
13

Role of Postmarketing Surveillance in Contemporary Medicine *

Year:
2011
Language:
english
File:
PDF, 1.02 MB
english, 2011
16

The FDA Critical Path Initiative and Its Influence on New Drug Development*

Year:
2008
Language:
english
File:
PDF, 232 KB
english, 2008
18

Expediting drug development for serious illness: Trade-offs between patient access and certainty

Year:
2018
Language:
english
File:
PDF, 79 KB
english, 2018
21

A regulatory perspective on in vitro diagnostics

Year:
2006
Language:
english
File:
PDF, 678 KB
english, 2006
24

Improving Adverse Event Reporting for Compounded Drugs

Year:
2019
Language:
english
File:
PDF, 49 KB
english, 2019
25

Cytomatrix synthesis in MDCK epithelial cells

Year:
1990
Language:
english
File:
PDF, 1.23 MB
english, 1990
31

Remote sensing for land management and planning

Year:
1983
Language:
english
File:
PDF, 3.19 MB
english, 1983
40

Empowering microarrays in the regulatory setting

Year:
2006
Language:
english
File:
PDF, 56 KB
english, 2006
41

FDA introductory comments: clinical studies design and evaluation issues

Year:
2005
Language:
english
File:
PDF, 657 KB
english, 2005